BrainScope Named “Best New Diagnostic Technology Solution” in 2022 MedTech Breakthrough Awards Program BioBuzz
Annual awards program recognizes outstanding medical and healthcare technology products and companies
BETHESDA, Maryland–(BUSINESS WIRE)–May 11, 2022–Brain Assessment Device Innovator BrainScopeannounced today that it has been selected as “Best New Diagnostic Technology Solution” in the sixth annual MedTech Breakthrough Awards program hosted by Breakthrough MedTechan independent market intelligence organization that recognizes the best companies, technologies and products in the global health and medical technology markets.
BrainScope is an FDA-cleared Class 2 wearable medical device that uses artificial intelligence (AI) and machine learning (ML) technology to identify objective biomarkers of structural and functional brain damage in patients with suspected brain damage. mild traumatic brain injury (mTBI).
BrainScope enables clinicians to triage mTCBs at the point of care without radiation and with a demonstrated 30% to 60% reduction in unnecessary computed tomography (CT) of the head. BrainScope is suitable for patients presenting to emergency departments, urgent care centers, and concussion clinics, as well as patients practicing sports or in the military. In less than 20 minutes from patient preparation to result, BrainScope provides an intuitive, easy-to-use tool for the operator and accurate, actionable results immediately available to the healthcare professional.
“What an honor to receive this award from MedTech Breakthrough. It validates the work of our entire team as we strive to improve brain health by providing objective diagnostic information that enables better patient care,” said Dr. Diku Mandavia, Chief Medical Officer at BrainScope, “BrainScope helps answer key questions clinicians and patients have: whether the patient has suffered a brain hemorrhage or concussion, and whether they are ready to return to normal activities. technology brought by BrainScope has immediate benefits for both the patient and the emergency department – the timing of this 21st century approach couldn’t be better.
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize innovation, hard work and success in a range of medical and health technology categories, including telehealth, clinical delivery, patient engagement, electronic health records (EHR), virtual care, medical care. Devices, medical data and many more. This year’s program attracted over 3,900 nominations from over 15 different countries around the world.
“Traumatic brain injury is at near epidemic levels in the United States with five million head-injured patients receiving care in emergency departments each year and while CT scans remain the standard of care, these scans cannot detect that the presence or absence of a brain bleed and do not detect a concussion,” said James Johnson, general manager of MedTech Breakthrough. “BrainScope is the only system that aids in the full spectrum assessment of mild traumatic brain injury, including brain bleeds and concussions. It’s truly point-of-care and takes just minutes from preparing the patient for results – a real breakthrough that we’re thrilled to recognize in our sixth annual MedTech Breakthrough Awards program.
BrainScope’s FDA cleared technology is exceptionally validated, published and patented, through 29 clinical studies, over 14,000 subject evaluations, 8 FDA and 2 Health Canada clearances, MDSAP and ISO13485 certifications, 31 publications reviewed peer review and 90 global patents granted.
BrainScope’s FDA-cleared EEG algorithms help clinicians rule out brain bleeds, assess concussion and concussion severity, and make accurate diagnosis and referral across the continuum of care.
BrainScope is a medical neurotechnology company that improves brain health by providing objective diagnostic information that enables better patient care. BrainScope is leading the way in rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), using multiple built-in assessment capabilities, artificial intelligence (AI), and scanning. The company’s technology supports the American College of Emergency Physicians’ (ACEP) Choose Wisely® campaign to avoid CT scans of the head in emergency department patients with minor head trauma. BrainScope’s innovative EEG-based and AI-derived algorithms enable physicians to quickly perform accurate assessments of traumatic brain injury, addressing the full spectrum of traumatic brain injury, from structural damage (cerebral hemorrhage) to functional injury (concussion), providing for the first time a complete image of the injury, in less time and without radiation. For more information, please visit www.brainscope.com.
About MedTech Breakthrough
Part of Technological breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is dedicated to recognizing excellence in companies, products, services and people from medical and health technologies. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough medical and medical companies and products in categories including Patient Engagement, Mobile Health, Health & Fitness, Administration clinical, healthcare IoT, medical data, healthcare cybersecurity and more. For more information, visit MedTechBreakthrough.com.
Vice President, Brand Experience
- About the Author
- Latest posts
BioBuzz is a community-driven, experiential, biotechnology and life sciences media and events company. BioBuzz highlights the latest regional news, industry professionals, jobs, events and resources for business and career growth. Their weekly newsletter is subscribed to by thousands of people in the Biohealth Capital Area and Greater Philadelphia as a go-to for industry updates.